X chromosome inactivation escape and skewing are discussed in a narrative review covering autoimmune, neurodevelopmental, cardiovascular, and cancer conditions
This narrative review examines the role of X chromosome inactivation escape and XCI skewing in female cells. The scope of the discussion extends to autoimmune disorders, neurodevelopmental disorders, cardiovascular diseases, and cancer. No specific study population, sample size, or setting is reported in the source text.
The authors do not provide primary or secondary outcome data, nor do they report adverse events or tolerability information. Consequently, no specific numerical results or pooled effect sizes are available for synthesis. The review focuses on the biological concepts rather than presenting trial-level evidence.
Limitations regarding the lack of reported data are inherent to the narrative format. The authors do not specify funding sources or conflicts of interest. Practice relevance is not explicitly defined in the provided text. Clinicians should interpret these qualitative discussions as background information rather than evidence for specific clinical decisions.